Horizon Pharma, Inc. (Nasdaq: HZNP) announced that Skyepharma has received a Notice of Allowance from the United States Patent and ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE